CARLA ROHENA: Open Payments
NPI 1629297411 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,946 in 83 payments from 18 companies in 2025. Trend: 2023 $1,313 · 2024 $1,800 · 2025 $1,946
Food & beverage: $1,762Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $337 |
| UCB, Inc. | 7 | $316 |
| GENZYME CORPORATION | 12 | $279 |
| Novartis Pharmaceuticals Corporation | 12 | $250 |
| Regeneron Healthcare Solutions, Inc. | 5 | $120 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $115 |
| ABBVIE INC. | 6 | $107 |
| E.R. Squibb & Sons, L.L.C. | 5 | $96 |
| Organon LLC | 7 | $60 |
| Lilly USA, LLC | 3 | $53 |
Products named: DUPIXENT, TREMFYA, Bimzelx, COSENTYX, Sotyktu, SKYRIZI, ADBRY, OPZELURA.
Industry payments across NC — which companies pay providers there.
